Category: Boston

Zaius Secures $8,000,000 New Funding

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=175a0133-9058-4723-91e5-35322f2ea51a Date 4/25/2016 Company Name Zaius Mailing Address 101 Main 17th Floor Cambridge, MA 02142 USA Company Description How well do you really know your customers? Zaius simplifies how you collect, analyze and act on your customer data to deliver digital intuition. Website http://www.zaius.com Transaction Type Venture Equity Transaction Amount $8,000,000 Transaction … Continue reading “Zaius Secures $8,000,000 New Funding”

Woven Orthopedic Receives $1,150,000 Series A Funding Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=0d9275d1-294a-4dbf-baf0-f7234115b53e Date 4/25/2016 Company Name Woven Orthopedic Mailing Address 63 East Center St. Manchester, CT 06040 USA Company Description Woven Orthopedic Technologies is a medical device business that designs and develops orthopedic technologies to treat the rapidly aging global population affected by orthopedic conditions (OrthoGeriatrics). Website http://www.wovenorthopedics.com Transaction Type Venture Equity Transaction … Continue reading “Woven Orthopedic Receives $1,150,000 Series A Funding Round”

Desktop Metal Obtains $33,760,835 New Funding

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=976078bc-2897-4f12-9630-0e9f9f9de5bf Date 4/25/2016 Company Name Desktop Metal Mailing Address 29 Hartwell Ave. Lexington, MA 02421 USA Company Description Desktop Metal is the effortless way to go from 3D CAD to robust metal parts. Our family of 3D printers will build complex parts beautifully and at a price that makes it attainable by … Continue reading “Desktop Metal Obtains $33,760,835 New Funding”

With New Partner, Rackspace Builds Out Support for Rivals’ Clouds

San Antonio — [Updated 4/27/16, 3:32 p.m. See below.] Cloud-computing giant Rackspace has made a deal to work with a Boston company that helps large businesses transfer their IT services to cloud-based infrastructures like Amazon Web Services. It’s a move that comes as Rackspace is increasingly finding ways to make money along with the public … Continue reading “With New Partner, Rackspace Builds Out Support for Rivals’ Clouds”

Boston Tech Watchlist: PillPack, Onshape, Placester, Meta, Northeastern

This week in Boston tech, we’re tracking the latest on PillPack, Placester’s first acquisitions, more money for Onshape, a Boston-area hire by Silicon Valley augmented reality startup Meta, and a nanotech manufacturing program at Northeastern University. Read on for details. —Onshape appears to have tacked on $25 million to an earlier $80 million equity funding … Continue reading “Boston Tech Watchlist: PillPack, Onshape, Placester, Meta, Northeastern”

Uber’s $100M Settlement Doesn’t End On-Demand Economy Worker Debate

Uber has agreed to pay up to $100 million to settle two class-action lawsuits brought by drivers in California and Massachusetts, a move that keeps its low-cost business model intact and could have ripple effects throughout the app-enabled, on-demand services industry. Uber’s settlement allows it to continue classifying its drivers in those two states as … Continue reading “Uber’s $100M Settlement Doesn’t End On-Demand Economy Worker Debate”

West Coast Bio Roundup: Prince, Theranos, Second Genome, CytomX & More

The biggest biomedical news on this coast, that coast, or any coast this week is the death of Prince Rogers Nelson, 57, a man who did more to promote cardiovascular fitness than any drug maker could ever hope to do. How much of your life have you spent dancing to his music, or, ahem, engaged … Continue reading “West Coast Bio Roundup: Prince, Theranos, Second Genome, CytomX & More”

Allergan Plc Acquires Topokine Therapeutics for $85,000,000

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=5b56981c-bea0-4c4a-a9b4-3483304cbb1c Date 4/22/2016 Company Name Topokine Therapeutics Mailing Address 60 South Street Boston, MA 02111 USA Company Description Topokine is a Boston-based, clinical-stage biotechnology company developing topical medications to contour the face and body non-invasively. Our initial focus is on facial aesthetics. Today, the only available therapies to contour the face and … Continue reading “Allergan Plc Acquires Topokine Therapeutics for $85,000,000”

Boston Startups Combat New Threats in Cybersecurity “War Zone”

Ed Davis doesn’t look like he would be fazed by anything. The former commissioner of the Boston Police Department has seen the kind of horrors he can’t erase from his mind—including the Boston Marathon bombing and its aftermath—but he has moved on. Now, a new type of threat has crept into his psyche. This one … Continue reading “Boston Startups Combat New Threats in Cybersecurity “War Zone””

Announcing Xconomy Cybersecurity Channel

It doesn’t seem to matter where you live, what you do, or what industry your company is in—the likelihood of a cyber attack is growing, and protecting yourself is ever more front of mind. Xconomy’s editors around the United States have certainly encountered that reality, as they are increasingly covering more and more cybersecurity issues. … Continue reading “Announcing Xconomy Cybersecurity Channel”

With BioMarin Data, Gene Therapy Finally Shows Impact on Hemophilia A

It’s too early to call it a breakthrough, but for the first time, a gene therapy has been shown to have a real impact on patients with hemophilia A, the most common form of the chronic blood disease. The early data, which come with plenty of caveats, were reported today by BioMarin (NASDAQ: [[ticker:BMRN]]), of … Continue reading “With BioMarin Data, Gene Therapy Finally Shows Impact on Hemophilia A”

NewCo Boston Festival of Innovation

From the event organizers: “Connect to Boston’s tech industry like never before. Explore the forces driving Boston with founders and senior leadership as your guide. We take you backstage, connecting you with founders and thought leaders. NewCo turns the business conference model inside out. Festival participants pick the companies they want to explore. Then, they … Continue reading “NewCo Boston Festival of Innovation”

WiredWest Needs State Help to Bring Broadband to Western MA: Report

Verizon’s plan to wire Boston with Fios, its high-speed fiber optic network, isn’t the only proposal for turbocharging the state’s Internet access speeds. In western Massachusetts, a startup effort formed by more than two dozen towns is planning a high-speed fiber optic network operated as a municipal cooperative company. The public startup organization is called … Continue reading “WiredWest Needs State Help to Bring Broadband to Western MA: Report”

Credential Stealing as Attack Vector

Traditional computer security concerns itself with vulnerabilities. We employ antivirus software to detect malware that exploits vulnerabilities. We have automatic patching systems to fix vulnerabilities. We debate whether the FBI should be permitted to introduce vulnerabilities in our software so it can get access to systems with a warrant. This is all important, but what’s … Continue reading “Credential Stealing as Attack Vector”

Bluebird’s Gene Therapy Shows Promise in Rare Brain Disease

Cerebral adrenoleukodystrophy is a rare, crippling neurological disease that leaves its patients, typically boys, severely disabled and ultimately dead in a matter of years. Only painful, dangerous bone marrow transplants can stop the progression of CALD. But while the transplants are effective in many cases, they can also be deadly for the patients who get … Continue reading “Bluebird’s Gene Therapy Shows Promise in Rare Brain Disease”

Probing Gut Microbiome, Second Genome Nabs $43M To Push Colitis Drug

[Corrected, 4/20/16, 2pm. See below.] Second Genome, a South San Francisco, CA-based biotech using microbiome research to develop traditional small-molecule drugs, has tapped an unusual group of private investors for nearly $43 million in a Series B round of financing. The cash should take Second Genome through a Phase 2 trial for its lead drug, … Continue reading “Probing Gut Microbiome, Second Genome Nabs $43M To Push Colitis Drug”

2016 NEVY Awards

From the event organizer, the New England Venture Capital Association: “Presented by Johnson & Johnson Innovation | JJDC, the NEVYs are the only event bringing together New England’s Tech and Life Science communities for an unforgettable evening of celebration. Dust off your ten gallon hat, shine your boots, and ride on over to the House … Continue reading “2016 NEVY Awards”

Threat Stack Downloads $15.4M to Protect Data in the Cloud

An up-and-coming Boston cybersecurity company just picked up a big chunk of cash to help companies fight off software attacks—an increasingly complex task in the cloud era. Threat Stack today announced a $15.4 million Series B funding round led by Scale Venture Partners, with contributions from previous backers, including Accomplice and .406 Ventures. Ariel Tseitlin, … Continue reading “Threat Stack Downloads $15.4M to Protect Data in the Cloud”

Ready Or Not: Next Alzheimer’s Drugs Might Strain Health Systems

By 2029, more than 20 percent of people in the United States will be over the age of 65. That’s why the race to find effective treatments for Alzheimer’s disease feels urgent. A few drugs, approved well over a decade ago, can slow patients’ mental decline for some time. But everything else that has reached … Continue reading “Ready Or Not: Next Alzheimer’s Drugs Might Strain Health Systems”

Nanosys, QD Vision Patent Fight Could Shake Up Nanotech Sector

As consumer device makers keep upping the ante with high-definition displays, a patent lawsuit between two well-funded, competing developers of “quantum dot” display technology could have ramifications for an emerging business sector. Milpitas, CA-based nanotechnology company Nanosys is suing Lexington, MA-based QD Vision for allegedly infringing upon 13 patents that Nanosys says it exclusively licensed … Continue reading “Nanosys, QD Vision Patent Fight Could Shake Up Nanotech Sector”

Curbside Lands New Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=e0eb22eb-4ab6-4e10-933b-162b9f8f370d Date 4/19/2016 Company Name Curbside Mailing Address 500 Cummings Center Palo Alto, MA 01915 USA Company Description The Curbside app allows you to find and buy products available at nearby stores such as Target. When your order is ready to pick up, we notify you. Website http://www.curbside.com Transaction Type Venture Equity … Continue reading “Curbside Lands New Round”

Agenda Posted For Napa Summit: Request Invite to Star-Studded Event

It’s four weeks until Napa Summit 2016: The Xconomy Retreat on the Economy, Jobs, and Growth. We have now posted the agenda, and we’d love to see you there. So request your invitation today to Xconomy’s most prestigious event. The dates are May 16 and 17, starting with a wine reception and dinner at Silver … Continue reading “Agenda Posted For Napa Summit: Request Invite to Star-Studded Event”

ShopAdvisor Buys Retailigence to Marry Mobile With In-Store Shopping

ShopAdvisor has acquired Retailigence in a tie-up of two marketing technology startups that highlights a push by brands and retailers to get smarthphone-wielding shoppers to make purchases in stores. The deal price wasn’t disclosed. ShopAdvisor was founded in 2011 as Evoqu and initially launched with an app that allows shoppers to scan barcodes of items and … Continue reading “ShopAdvisor Buys Retailigence to Marry Mobile With In-Store Shopping”

Chiasma Shares Crater as FDA Rejects Hormone Drug, Asks For More Data

Chiasma was on the doorstep of possible of approval of its first drug, a potential treatment for a rare hormonal disorder called acromegaly. Now the Waltham, MA-based company is going to stay there for awhile, because the FDA believes it has a lot more data to accrue before approval is granted. Late Friday, Chiasma (NASDAQ: … Continue reading “Chiasma Shares Crater as FDA Rejects Hormone Drug, Asks For More Data”

Organogenesis Obtains $30,000,000 New Financing Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=eb5ba27d-2c8b-47f4-8fdc-1e234847a735 Date 4/18/2016 Company Name Organogenesis Mailing Address 85 Dan Road Canton, MA 02021 USA Company Description Having pioneered the field, Organogenesis Inc. is a commercial leader in regenerative medicine, focused in the areas of bio-active wound healing and soft tissue regeneration. The company was originally founded in 1985 as a spin-off … Continue reading “Organogenesis Obtains $30,000,000 New Financing Round”

Allyke Secures $1,300,000 Seed Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=9d08d068-b6fd-4ae4-8ec4-67617dbc40d9 Date 4/18/2016 Company Name Allyke Mailing Address 14 Mica Lane Wellesley, MA 02481 USA Company Description Allyke was founded on the simple vision of giving omni-channel retailers the power to deliver a complete visual shopping experience that drives consumers to buy. Imagine allowing your consumers to feel the positive emotion of … Continue reading “Allyke Secures $1,300,000 Seed Round”

INFLUX Boston

GE. Dell. IBM Watson Health. Lilly. Toyota. Amazon. A flood of fresh faces is poised to reshape Boston’s already-vibrant innovation scene, as high-flying companies open R&D arms, move into new digs, and expand their campuses—joining a wave of disruptive new startups. It’s nothing less than an INFLUX of talent and opportunity. #INFLUXboston

First-Quarter VC Activity Buoyant at $12.1 Billion, & Top 10 Deals

Venture capital firms invested $12.1 billion in 969 startup deals nationwide during the first three months of 2016, marking the ninth consecutive quarter when VCs invested at least $10 billion in new companies, according to the MoneyTree Report. The top 10 deals accounted for 25 percent of all capital deployed during the quarter, and was … Continue reading “First-Quarter VC Activity Buoyant at $12.1 Billion, & Top 10 Deals”

Threat Stack Receives $15,367,290 New Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=fffa8732-2422-4e48-a3dc-47c0f79adbd0 Date 4/15/2016 Company Name Threat Stack Mailing Address 266 Summer Street 3rd Floor Boston, MA 02210 USA Company Description A cloud-native platform that runs on any platform and delivers the uni?ed experience. The best way to identify insider threats, external attacks, data loss & meet compliance. Website http://www.threatstack.com Transaction Type Venture … Continue reading “Threat Stack Receives $15,367,290 New Round”

Vestmark Lands $30,000,000 New Funding

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=53f629cf-c0e8-4ae8-a9db-e185c2f99883 Date 4/15/2016 Company Name Vestmark Mailing Address 100 Quannapowitt Parkway Wakefield, MA 01880 USA Company Description Vestmark’s vision is to create a world-class technology platform and service offering that enables the development, distribution, and management of innovative investment solutions for individual and institutional investors. Website http://www.vestmark.com Transaction Type Venture Equity Transaction … Continue reading “Vestmark Lands $30,000,000 New Funding”

SciAps Secures $1,043,179 New Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=25d1ec49-927f-44e4-8bc0-ebc2054a208b Date 4/15/2016 Company Name SciAps Mailing Address 2 Constitution Way Woburn, MA 01801 USA Company Description SciAps, Inc., is a Boston-based instrumentation company specializing in portable analytical instruments. Our mission is to provide durable, field-tested, portable instruments to identify any compound, any mineral, any element — anyplace on the planet. Website … Continue reading “SciAps Secures $1,043,179 New Round”

PillPack Puts Pressure on Express Scripts in Pharmacy Dispute

[Updated, 10:30pm. See below] It’s a timeworn tale: a startup forms a key partnership with a big company, only to see said company change the terms or end the deal. Think Microsoft, Amazon, or any other giant throwing its weight around with smaller players. Now think healthcare—and a fight between one of the fastest-growing local … Continue reading “PillPack Puts Pressure on Express Scripts in Pharmacy Dispute”

With $40M Led by GV, Quartet Expands Tech for Mental Health Care

Quartet Health, the data-focused New York company that is trying to connect what it calls behavioral and physical healthcare, has received a $40 million Series B round led by GV, the venture capital arm of Google’s parent company, Alphabet. Quartet plans to spend the new money on gaining clients in five to 10 more major … Continue reading “With $40M Led by GV, Quartet Expands Tech for Mental Health Care”

Verizon Fios, New Digs, Pink Slips & More in Boston Tech Watchlist

[Updated 4/14/16, 1:06 p.m. See below.] There’s a lot of news to recap this week in Boston’s tech scene. We’ve got C-suite shakeups, staff expansions and contractions, and companies making moves in telehealth, robotics, and high-speed Internet service (spoiler alert: there will be more options for Bostonians, but you might be waiting a while). Read … Continue reading “Verizon Fios, New Digs, Pink Slips & More in Boston Tech Watchlist”

East Coast Biotech Roundup: Intellia, What’s Hot, Cydan, Fog & More

Gene editing was in the news again this week, thanks to Intellia Therapeutics, which looks poised to become the second company developing drugs with CRISPR-Cas9 technology to go public. It wouldn’t be a surprise to see a third, CRISPR Therapeutics, follow suit. That means investors will have a chance to place and hedge their bets … Continue reading “East Coast Biotech Roundup: Intellia, What’s Hot, Cydan, Fog & More”

Cydan, NEA’s Orphan Drug Accelerator, Targets Sickle Cell With Startup Imara

Cydan Development, New Enterprise Associates’s orphan drug startup accelerator, has taken a look at around 600 assets since it was formed some three years ago. Sifting through all these potential drugs for diamonds in the rough has been an exhaustive process, perhaps even more so than the firm’s executives expected. “It takes longer to de-risk … Continue reading “Cydan, NEA’s Orphan Drug Accelerator, Targets Sickle Cell With Startup Imara”

Kala Pharmaceuticals Garners $68,000,000 Series C Funding Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=e947e707-9ea3-401a-a2c6-dd9abf1602f8 Date 4/14/2016 Company Name Kala Pharmaceuticals Mailing Address 100 Beaver St. Waltham, MA 02453 USA Company Description Kala Pharmaceuticals, Inc. is a biotechnology company founded upon a proprietary drug delivery technology. By utilizing this unique technology, Kala aims to address unmet therapeutic needs of various diseases and conditions in a fundamentally … Continue reading “Kala Pharmaceuticals Garners $68,000,000 Series C Funding Round”

Kala Pharma Nabs $68M, Crossover Backers for Eye Drug Push

It’s been a common sight over the past few years for a biotech startup to bring a bunch of “crossover” investors—who invest in both public and private companies—into the mix before taking a crack at an IPO. Kala Pharmaceuticals just got the first part of that done by raising a $68 million Series C round … Continue reading “Kala Pharma Nabs $68M, Crossover Backers for Eye Drug Push”

After EMC, Dell Buyouts, Spanning Focused on Data Backup, Ransomware

Austin — The broad-stroke reasoning behind the Dell and EMC merger has been discussed for months: Dell is hoping to benefit from being able to simultaneously offer its computers, servers, and other hardware alongside EMC’s data storage, virtualization, security, and various other computing and data-focused services. But there are other parts of Hopkinton, MA-based EMC (NYSE: … Continue reading “After EMC, Dell Buyouts, Spanning Focused on Data Backup, Ransomware”

Nexthink Nabs $40M as Cybersecurity, Machine Learning Unite

A Swiss data analytics and cybersecurity company is beefing up its Boston-area presence after grabbing $40 million in venture capital, led by Highland Europe. Nexthink established a U.S. presence three weeks ago with the opening of a sales office in Cambridge, MA. The company employs about 10 people there to start, but it plans to … Continue reading “Nexthink Nabs $40M as Cybersecurity, Machine Learning Unite”

With Latest Startup, Harvard’s Verdine Again Aims at Elusive Targets

Harvard University chemical biologist and serial entrepreneur Greg Verdine has spent more than a decade trying to come up with different solutions for one critical problem in biotech: The majority of would-be drug targets are out of reach of existing technologies. That drive has already led to several different companies—among them Aileron Therapeutics, Warp Drive … Continue reading “With Latest Startup, Harvard’s Verdine Again Aims at Elusive Targets”

Nexthink Lands $40,000,000 New Financing Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=53c1e15f-5360-4cc5-8cea-92a3cc92da49 Date 4/13/2016 Company Name Nexthink Mailing Address One Broadway 16th Floor Boston, MA 02142 USA Company Description NEXThink SA was founded in 2004 within the artificial intelligence laboratory of the Swiss Federal Institute of Technology Lausanne (EPFL). NEXThink develops and distributes a unique, patented solution. Website http://www.nexthink.com Transaction Type Venture Equity … Continue reading “Nexthink Lands $40,000,000 New Financing Round”

Sonitor Technologies Secures $9,500,000 New Financing

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=0bbe36d1-79d0-42b5-8770-a79de3b43439 Date 4/13/2016 Company Name Sonitor Technologies Mailing Address 1010 Washington Boulevard 9th Floor Stamford, CT 06901 USA Company Description Sonitor Technologies’ RTLS technology is designed for seamless integration with third party applications software and integration solutions. Website http://www.sonitor.com Transaction Type Venture Equity Transaction Amount $9,500,000 Transaction Round Undisclosed Proceeds Purposes This … Continue reading “Sonitor Technologies Secures $9,500,000 New Financing”

Shapeways CEO Calls Again for 3D Printing Revolution in Manufacturing

At this afternoon’s Inside 3D Printing Conference & Expo held in New York, Shapeways CEO and co-founder Peter Weijmarshausen will give a keynote address on the potential he sees in the long-promised age of digital manufacturing—which, frankly, still has a ways to go before it takes hold with the masses. Shapeways, based in New York, produces 3D-printed … Continue reading “Shapeways CEO Calls Again for 3D Printing Revolution in Manufacturing”

Amazon Alexa Adds Health Advice With Boston Children’s Hospital App

Owners of Amazon’s voice-controlled, Internet-connected Echo speaker can ask it to play that catchy new song or find out whether they need to wear a rain coat today. And now, thanks to new software developed by Boston Children’s Hospital, users will be able to inquire if their child’s fever is serious enough that they should … Continue reading “Amazon Alexa Adds Health Advice With Boston Children’s Hospital App”

Cambrooke Therapeutics Garners Series C Funding Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=982ebb8a-1461-4ec0-86d3-2c5a6b6edb42 Date 4/12/2016 Company Name Cambrooke Therapeutics Mailing Address 4 Copeland Drive Ayer, MA 01432 USA Company Description Founded in 2000, Cambrooke is a private equity-backed, Massachusetts-based therapeutic nutrition company and global provider of medical nutrition products for patients with serious chronic unmet medical needs. Website http://www.cambrooke.com Transaction Type Venture Equity Transaction … Continue reading “Cambrooke Therapeutics Garners Series C Funding Round”

CRISPR Developer Intellia Deals With Regeneron, Jumps Into IPO Queue

Intellia Therapeutics, a developer of human medicines based on the gene editing technology CRISPR-Cas9, has thrown its hat in the IPO ring. It’s also shooting directly at the liver. The Cambridge, MA-based company filed paperwork to go public today. It also announced a deal with Tarrytown, NY-based Regeneron Pharmaceuticals (NASDAQ: [[ticker:REGN]]) to develop a therapy … Continue reading “CRISPR Developer Intellia Deals With Regeneron, Jumps Into IPO Queue”